FDA clears pTau217 blood test for Alzheimer's disease
-
By
-
Kathryn Wighton
-
August 24, 2026
-
2 min
By
Kathryn Wighton
August 24, 2026
Older adults with anemia showed elevated Alzheimer-related biomarkers and a higher hazard of dementia over follow-up
April 28, 2026
Several FDA decisions across multiple specialties are expected this month.
April 29, 2026
Federal prosecutors allege that a Florida physician and research staff fabricated clinical trial records that were submitted into database systems used to evaluate investigational drugs.
June 11, 2026